Sigma Healthcare Limited
SIG
Clasificación en acciones
#1051
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Precio por acción
$1.93
Capitalización bursátil
$22.23B
Cambio (1 día)
-0.90%
Cambio (1 año)
-2.07%
País
AU
Comercio Sigma Healthcare Limited (SIG)
Categoría
Healthcare
Ratio P/E de Sigma Healthcare Limited (SIG)
Ratio P/E al October 2026 TTM: 45.62
Según los últimos informes financieros y el precio de las acciones de Sigma Healthcare Limited, el P/E actual (TTM) de la empresa es 45.62. Al final de 2024, la empresa tenía un P/E de 234.02.
Historial del ratio P/E de Sigma Healthcare Limited desde 2001 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 45.62 | -114.00% |
| 2025 | -325.86 | -239.25% |
| 2024 | 234.02 | -26.24% |
| 2023 | 317.28 | -665.12% |
| 2022 | -56.14 | -501.98% |
| 2021 | 13.97 | -132.08% |
| 2020 | -43.54 | -428.15% |
| 2019 | 13.27 | -11.29% |
| 2018 | 14.96 | -30.16% |
| 2017 | 21.42 | 38.38% |
| 2016 | 15.48 | 4.98% |
| 2015 | 14.74 | 39.21% |
| 2014 | 10.59 | -78.60% |
| 2013 | 49.48 | 283.29% |
| 2012 | 12.91 | -743.40% |
| 2011 | -2.01 | -2.21% |
| 2010 | -2.05 | -110.26% |
| 2009 | 19.99 | -22.66% |
| 2008 | 25.85 | -25.53% |
| 2007 | 34.72 | -2.21% |
| 2006 | 35.50 | 0.00% |
| 2004 | 0.00 | -100.00% |
| 2003 | 336.99 | -27.92% |
| 2002 | 467.50 | -41.33% |
| 2001 | 796.84 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 26.02 | -42.96% |
US
|
|
| - | - |
US
|
|
| 34.08 | -25.30% |
US
|
|
| - | - |
US
|
|
| 24.73 | -45.79% |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.